CVS stock rebounds after Medicare Advantage rate scare; what investors watch next
CVS shares rose about 3% Wednesday morning, rebounding after a 14% drop tied to a draft Medicare Advantage payment update from CMS. The proposal would raise 2027 payments by just 0.09% on average, below Wall Street forecasts. Investors await CVS’s Feb. 10 earnings call and CMS’s final rate decision on April 6.